Access cutting-edge erythropoietic protoporphyria treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access erythropoietic protoporphyria specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related erythropoietic protoporphyria treatment provided free
The goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to answer are: * Whether bitopertin increases pain-free sunlight exposure after 6 months of treatment in participants with EPP or XLP. * How PPIX concentration levels change from before bitopertin treatment to after 6 months of treatment. Researchers will compare bitopertin to a placebo look-alike substance that contains no drug. Partici
Sponsor: Disc Medicine, Inc
Check if you qualify for this erythropoietic protoporphyria clinical trial in New York, NY
If you're searching for erythropoietic protoporphyria treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced erythropoietic protoporphyria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.